Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatrics ; 115(1): 83-8, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15629985

ABSTRACT

OBJECTIVE: Methylxanthines and doxapram are currently used to treat apnea of prematurity but are not fully effective and often present undesirable side effects. The present study examines whether exposure to an odor known to modulate the infant's respiratory rate could reduce the frequency of apneic spells. METHOD: Fourteen preterm newborns born at 24 to 28 gestational weeks presenting recurrent apnea despite caffeine and doxapram therapy were exposed to a pleasant odor diffused during 24 hours in the incubator. Efficiency of the olfactory treatment was judged by comparing frequency and severity of apneas occurring during the day of odorization with that observed the day before (baseline) and the day after (posttreatment control). Apnea was defined as any complete cessation of breathing movements for >20 seconds, or less if associated with hypoxia or bradycardia. RESULTS: Concerning all types of apneas, a diminution of 36% was observed and seen in 12 of 14 infants. Apneas without bradycardia were reduced (44%) during the day with odorization, and this diminution affected all the infants. The frequency of apnea with moderate bradycardia (heart rate between 70 and 90 beats per minute) was maintained while the frequency of apnea associated with severe bradycardia (heart rate <70 beats per minute) decreased strongly (45%) and affected all the infants. No side effects were observed. CONCLUSION: The introduction of a pleasant odor in the incubator is of therapeutic value in the treatment of apneas unresponsive to caffeine and doxapram.


Subject(s)
Apnea/prevention & control , Aromatherapy , Infant, Premature, Diseases/prevention & control , Smell , Apnea/complications , Bradycardia/etiology , Caffeine/therapeutic use , Central Nervous System Stimulants/therapeutic use , Combined Modality Therapy , Doxapram/therapeutic use , Drug Therapy, Combination , Humans , Infant, Newborn , Infant, Premature , Odorants , Physical Stimulation , Respiratory System Agents/therapeutic use
2.
J Perinatol ; 24(5): 317-8, 2004 May.
Article in English | MEDLINE | ID: mdl-15116128

ABSTRACT

We report the first case to be observed in a neonate of an intramural bronchogenic cyst in the carina. Considering the age of the infant, it was decided to administer curative treatment by needle aspiration. A rigid bronchoscopy was used. The outcome was favorable.


Subject(s)
Bronchogenic Cyst/diagnosis , Biopsy, Needle , Bronchogenic Cyst/therapy , Bronchoscopy , Female , Humans , Infant, Newborn
3.
J Perinatol ; 24(4): 259-60, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15067297

ABSTRACT

Necrotizing tracheobronchitis is a serious affection observed in ventilated newborns, frequently infants with instable hemodynamic state. It is characterized by acute episodes of airway obstruction. The treatment consists of the desobstruction by rigid bronchoscopy. The vascular theory seems to be of utmost importance in the physiopathology. Three cases are reported.


Subject(s)
Bronchitis/etiology , Respiration, Artificial/adverse effects , Tracheitis/etiology , Airway Obstruction/etiology , Bronchitis/pathology , Bronchoscopy , Female , Humans , Infant, Newborn , Intubation, Intratracheal , Male , Necrosis , Tracheitis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...